← All trials
NCT03759405
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2019
- Primary completion
- Jul 19, 2019
- Completion date
- May 19, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 3
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peking UniversityLead sponsor
- Peking UniversityReponsible party - principal investigator
- Peking UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.